371 In osteoblasts, the administration of GLP-1 and GIP incretins suppressed the excessive expression of the pro-degradative enzymes MMP-3 and MMP-13 induced by IL-1 stimulation
While oral formulations offer the convenience of a pill compared to traditional injections, this shift also raises important compliance considerations
After the start of GLP-1RA treatment, participants were deemed to have discontinued the drug if they did not receive a refill for 90 days after their prescription ended
Petrovic, A
Retrieved from Yaribeygi, H., Jamialahmadi, T., Moallem, S
Risk of Fracture with Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Real-World Use: Systematic Review and Meta-Analysis of Observational Studies. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol